,sentence,pubmed_id,content,label,labeler
0,"2 |||  ||| 0.2 ||| Methods: 20 patients admitted within 24 h after the onset of a first AMI were randomly allocated to receive intracoronary autologous BMT (n = 10) or bone marrow supernatant (controls, n = 10) immediately after primary percutaneous coronary intervention.",16775089,20 patients,po.Size,lingtaiwei
1,"2 |||  ||| 0.2 ||| Methods: 20 patients admitted within 24 h after the onset of a first AMI were randomly allocated to receive intracoronary autologous BMT (n = 10) or bone marrow supernatant (controls, n = 10) immediately after primary percutaneous coronary intervention.",16775089,within 24 h after the onset of a first AMI,po.Disease,lingtaiwei
2,"2 |||  ||| 0.2 ||| Methods: 20 patients admitted within 24 h after the onset of a first AMI were randomly allocated to receive intracoronary autologous BMT (n = 10) or bone marrow supernatant (controls, n = 10) immediately after primary percutaneous coronary intervention.",16775089,"were randomly allocated to receive intracoronary autologous BMT (n = 10) or bone marrow supernatant (controls, n = 10)",i.Diagnostic,lingtaiwei
3,60 ||| DISCUSSION ||| 4.12 ||| Bone marrow was harvested one day after successful PCI for ST elevation myocardial infarction.,16775089,Bone marrow was harvested,i.Diagnostic,lingtaiwei
4,1 |||  ||| 0.1 ||| Objective: To study whether emergent intracoronary autologous bone marrow cell transplantation (BMT) is applicable for the treatment of acute myocardial infarction (AMI).,16775089,emergent intracoronary autologous bone marrow cell transplantation,pr.Disease,lingtaiwei
5,"52 ||| DISCUSSION ||| 4.4 ||| Moreover, emergent autologous bone marrow cell transfer does not increase the risk of adverse clinical events.",16775089,does not increase the risk of adverse clinical events,o.Patient,lingtaiwei
6,"50 ||| DISCUSSION ||| 4.2 ||| In a previous randomised study, Wollert et al 8 showed that intracoronary transplantation of autologous bone marrow cells during the early postinfarction period (within 4-8 days after symptom onset) improved global LVEF.",16775089,intracoronary transplantation of autologous bone marrow cells during the early postinfarction period (within 4-8 days after symptom onset) improved global LVEF,o.Treatment,lingtaiwei
7,"6 |||  ||| 0.6 ||| Conclusion: Emergent intracoronary transplantation of bone marrow mononuclear cells after AMI is practicable, and it improved cardiac function, prevented myocardial remodelling and increased myocardial perfusion at six months' follow up.",16775089," it improved cardiac function, prevented myocardial remodelling and increased myocardial perfusion at six months' follow up",o.Treatment,lingtaiwei
8,"40 ||| RESULTS ||| 3.8 ||| No angina aggravation, malignant diseases and substantial arrhythmias were found after PCI and intracoronary BMT or bone marrow supernatant transfer either in hospital or during follow up.",16775089,"No angina aggravation, malignant diseases and substantial arrhythmias",o.Treatment,lingtaiwei
